Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity

BACKGROUND/OBJECTIVES: Low-grade chronic inflammation in visceral adipose tissue and the intestines are important drivers of obesity associated insulin resistance. Bioactive compounds derived from plants are an important source of potential novel therapies for the treatment of chronic diseases. In s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Obes (Lond)
Autors principals: Lin, Yi-Hsuan, Luck, Helen, Khan, Saad, Schneeberger, Pierre H. H., Tsai, Sue, Clemente-Casares, Xavier, Lei, Helena, Leu, Yann-Lii, Chan, Yi Tao, Chen, Hsing-Yu, Yang, Sien-Hung, Coburn, Bryan, Winer, Shawn, Winer, Daniel A.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6892742/
https://ncbi.nlm.nih.gov/pubmed/30944419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41366-019-0340-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars